Fig. 5From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot studyAlteration in IL-6(plasma inflammatory factor). IL-6 in the control group, PBC group (pretreatment), before and after TN and before and after sham-TN). (n = 10 for each group)Back to article page